Skip to content

Clinical trials

Amyloid Neuropathies, Familial trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloid Neuropathies, Familial Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20211
20221
20232
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Unknown status2
Completed1
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tianjin Medical University2
AstraZeneca1
Beijing Anzhen Hospital1
Chinese Academy of Medical Sciences, Fuwai Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
First Hospital of China Medical University1
GenEditBio Limited1
Pfizer1
Qilu Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloid Neuropathies, Familial10
Amyloidosis3
Alzheimer Disease2
Fabry Disease2
Amyloid Neuropathies1
Amyloidosis, Familial1
Cardiomyopathies1
Cardiomyopathy, Hypertrophic1
Corneal Dystrophies, Hereditary1
Disease1

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.